10-Q: NewHydrogen Inc. Reports First Quarter 2024 Results, Net Loss Decreases Due to Non-Cash Stock Compensation Changes

Sentiment:

Quarterly Report


NewHydrogen Inc. reported a net loss of $471,004 for the first quarter of 2024, a decrease compared to the $1,631,500 loss in the same period of 2023, primarily due to changes in non-cash stock compensation expenses.

Capital raiseManagement believes that the company will be able to continue to raise funds through the sale of its securities to existing and new investors.Management estimates that it will require additional cash resources during 2025, based upon its current operating plan and condition.
Better than expectedThe company's net loss decreased significantly compared to the same period last year, primarily due to a decrease in non-cash stock compensation expenses.

Summary

  • NewHydrogen Inc. reported a net loss of $471,004 for the three months ended March 31, 2024, compared to a net loss of $1,631,500 for the same period in 2023.
  • The decrease in net loss was primarily due to a decrease in non-cash stock compensation expenses.
  • General and administrative expenses decreased by $1,234,562 to $381,376, mainly due to a reduction in non-cash stock compensation.
  • Research and development expenses increased by $73,939 to $88,939, driven by higher outside research fees.
  • The company's cash balance decreased to $3,247,036 as of March 31, 2024, from $3,678,441 at the end of 2023.
  • The company had a working capital of $3,285,252 and a shareholders deficit of $177,578 as of March 31, 2024.
  • NewHydrogen has not generated any revenue to date and is in the development stage.
  • Management believes the company's current cash flows will enable it to meet its obligations for twenty-four months from the date of these financial statements.

Sentiment

Score: 5

Explanation: The document shows a mixed sentiment. While the company has reduced its net loss and operating expenses, it is still in a development stage with no revenue and a shareholders deficit. The company's reliance on external funding and the auditor's going concern warning are significant concerns.

Positives

  • The company's net loss decreased significantly year-over-year, indicating improved cost management.
  • General and administrative expenses were substantially reduced, primarily due to lower non-cash stock compensation expenses.
  • The company has a research agreement with the University of California, which is expected to benefit the company's technology development.

Negatives

  • The company continues to operate at a loss and has not generated any revenue.
  • The company's cash balance decreased during the quarter.
  • The company has a shareholders deficit of $177,578 as of March 31, 2024.
  • The company's independent auditors have expressed substantial doubt about the company's ability to continue as a going concern without additional capital.

Risks

  • The company's ability to continue as a going concern is dependent on its ability to raise additional capital.
  • The company has not generated any revenue and is reliant on external funding.
  • The company's stock options and warrants could cause dilution for existing shareholders.
  • The company's research and development efforts may not be successful.
  • The company's financial statements do not include any adjustments that might result from the outcome of the uncertainty about the company's ability to continue as a going concern.

Future Outlook

Management believes that the company's current cash and investment balances will be sufficient to support development activity and general and administrative expenses for the next twenty-four months, and that additional cash resources will be required during 2025.

Management Comments

  • Management believes the company's present cash flows will enable it to meet its obligations for twenty-four months from the date of these financial statements.
  • Management will continue to assess its operational needs and seek additional financing as needed to fund its operations.
  • Management believes that funding from existing and prospective new investors and future revenue will provide the additional cash needed to meet our obligations as they become due and will allow the development of our core business operations.

Industry Context

The company is operating in the clean energy sector, specifically focusing on green hydrogen production, which is a growing area of interest due to the global push for renewable energy sources. The company's focus on thermochemical water splitting aims to address the high cost of green hydrogen production, which is a significant barrier to its widespread adoption.

Comparison to Industry Standards

  • NewHydrogen is a development stage company and does not have any revenue, which is not uncommon for companies in the early stages of technology development.
  • The company's focus on thermochemical water splitting is a novel approach compared to the more common electrolysis method, which could provide a competitive advantage if successful.
  • The company's research agreement with the University of California is a positive sign of its commitment to innovation and technology development.
  • The company's financial position is weak, with a shareholders deficit and reliance on external funding, which is a common challenge for early-stage companies in the clean energy sector.
  • The company's stock compensation expenses are high, which is a common practice for early-stage companies to attract and retain talent.

Stakeholder Impact

  • Shareholders may experience dilution if the company raises additional capital through equity financing.
  • Employees may be impacted by the company's financial situation and potential need for cost-cutting measures.
  • Customers and suppliers are not directly impacted at this stage as the company is still in the development phase.
  • Creditors may be concerned about the company's ability to repay its debts given its current financial situation.

Next Steps

  • The company plans to utilize its cash balances to maintain the existing ThermoLoop technology development program at UCSB.
  • The company will continue to seek additional financing to fund its operations.
  • The company expects to ramp up prototyping efforts related to its thermochemical water splitting technology in early 2026.

Key Dates

DateDescription
2021-02-18Initial grant of 450,000,000 stock options to employees.
2021-03-18First vesting installment of stock options.
2021-09-29Amendment of stock option exercise price.
2022-03-01Issuance of 5,000,000 common stock purchase warrants.
2022-03-15Grant of 5,000,000 stock options to a consultant.
2022-04-12Cancellation of previous stock options and grant of 450,000,000 new options to employees.
2023-03-11One employee separated from the company and 50,000,000 options were cancelled.
2023-03-20Grant of 50,000,000 stock options.
2023-05-09Grant of 5,000,000 stock options to a consultant.
2023-05-30Amendment to consultant agreement.
2023-06-15Grant of 100,000,000 stock options to two employees.
2023-08-01Research agreement with the Regents of the University of California.
2024-03-31End of the reporting period for the quarterly report.
2024-05-10Number of shares of common stock issued and outstanding was 704,599,512.
2024-05-13Date of the report.

Keywords

hydrogen, green hydrogen, thermochemical, stock options, warrants, research and development, financial statements, net loss, operating expenses, going concern

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.